Catalytically active bovine serum amine oxidase bound to fluorescent and magnetically drivable nanoparticles

Abstract

Novel superparamagnetic surface-active maghemite nanoparticles (SAMNs) characterized by a diameter of 10 ± 2 nm were modified with bovine serum amine oxidase, which used rhodamine B isothiocyanate (RITC) adduct as a fluorescent spacer-arm. A fluorescent and magnetically drivable adduct comprised of bovine serum copper-containing amine oxidase (SAMN–RITC–BSAO) that immobilized on the surface of specifically functionalized magnetic nanoparticles was developed. The multifunctional nanomaterial was characterized using transmission electron microscopy, infrared spectroscopy, mass spectrometry, and activity measurements. The results of this study demonstrated that bare magnetic nanoparticles form stable colloidal suspensions in aqueous solutions. The maximum binding capacity of bovine serum amine oxidase was approximately 6.4 mg g⁻¹ nanoparticles. The immobilization procedure reduced the catalytic activity of the native enzyme to 30% ± 10% and the Michaelis constant was increased by a factor of 2. We suggest that the SAMN–RITC–BSAO complex, characterized by a specific activity of 0.81 IU g^−1, could be used in the presence of polyamines to create a fluorescent magnetically drivable H₂O₂ and aldehydes-producing system. Selective tumor cell destruction is suggested as a potential future application of this system.

Keywords:

• amine oxidase
• hydrogen peroxide production
• superparamagnetic nanoparticles
• rhodamine isothiocyanate
• fluorescent nanoparticles
• fluorescent nanocatalyst

Acknowledgments

This work was funded in part by Progetti di Ateneo (A.0ED00.0487PRAT08), by the University of Padua, by the Italian MIUR (Ministero dell’Istruzione, dell’Università e della Ricerca), by Istituto Superiore di Sanità “ Project Italy- USA”, by Istituto Pasteur-Fondazione Cenci Bolognetti, and by funds MIUR-PRIN (Cofin). The work was supported by the Operational Program Research and Development for Innovations- European Social Fund (CZ.1.05/2.1.00/03.0058).

Disclosure

The authors report no conflicts of interest in this work.